Prenetics' IM8 Secures Exclusive Health Supplements Deal with Inter Miami CF
Event summary
- Prenetics' IM8 becomes the exclusive health supplements partner of Inter Miami CF in a multi-year deal.
- Inter Miami CF takes an equity stake in Prenetics, marking its first equity investment in a brand partner.
- IM8 products will be integrated into Inter Miami's daily performance and recovery routines for players and staff.
- IM8 gains group player name, image, and likeness (NIL) rights for at least four Inter Miami players.
- IM8 projects revenues of $180 million to $200 million for full-year 2026.
The big picture
This partnership strategically positions IM8 within the professional sports ecosystem, moving beyond individual athlete endorsements to a full-club integration model. Inter Miami's equity stake reflects deep long-term conviction in the IM8 brand, creating structural alignment between both organizations. The deal also provides IM8 with unparalleled access to matchday audiences and a rapidly growing global fanbase, amplifying its brand awareness in key growth markets outside the United States.
What we're watching
- Brand Credibility
- How IM8's full-club integration with Inter Miami will enhance its credibility in the professional sports ecosystem.
- Market Expansion
- Whether IM8 can leverage Inter Miami's global brand to amplify awareness in key international markets.
- Revenue Growth
- The pace at which IM8 can sustain its rapid revenue growth, projected to reach $180 million to $200 million in 2026.
Related topics